Fenyvesi F - Search Results

1

Biocompatibility and zinc release testing of a zinc-containing vaginal gel.

Fenyvesi F, Váradi J, Fehér P, Bácskay I, Vecsernyés M, Sipos A, Takacs P. Fenyvesi F, et al. Menopause. 2020 Feb;27(2):143-149. doi: 10.1097/GME.0000000000001435. Menopause. 2020. PMID: 31613827

2

In vivo assessment of tumor targeting potential of ⁶⁸Ga-labelled randomly methylated beta-cyclodextrin (RAMEB) and 2-hydroxypropyl-β-cyclodextrin (HPβCD) using positron emission tomography.

Szabó JP, Csige K, Kálmán-Szabó I, Arató V, Opposits G, Jószai I, Kertész I, Képes Z, Méhes G, Fenyvesi F, Hajdu I, Trencsényi G. Szabó JP, et al. Among authors: fenyvesi f. Int J Pharm. 2023 Jan 5;630:122462. doi: 10.1016/j.ijpharm.2022.122462. Epub 2022 Nov 30. Int J Pharm. 2023. PMID: 36462739 Free article.

3

Synthesis and cytotoxicity of leinamycin antibiotic analogues.

Szilagyi A, Fenyvesi F, Majercsik O, Pelyvas IF, Bacskay I, Fehér P, Varadi J, Vecsernyés M, Herczegh P. Szilagyi A, et al. Among authors: fenyvesi f. J Med Chem. 2006 Sep 7;49(18):5626-30. doi: 10.1021/jm060471h. J Med Chem. 2006. PMID: 16942037

4

Complete inhibition of P-glycoprotein by simultaneous treatment with a distinct class of modulators and the UIC2 monoclonal antibody.

Goda K, Fenyvesi F, Bacsó Z, Nagy H, Márián T, Megyeri A, Krasznai Z, Juhász I, Vecsernyés M, Szabó G Jr. Goda K, et al. Among authors: fenyvesi f. J Pharmacol Exp Ther. 2007 Jan;320(1):81-8. doi: 10.1124/jpet.106.110155. Epub 2006 Oct 18. J Pharmacol Exp Ther. 2007. PMID: 17050779

5

Cytotoxicity of different types of methylated beta-cyclodextrins and ionic derivatives.

Kiss T, Fenyvesi F, Pasztor N, Feher P, Varadi J, Kocsan R, Szente L, Fenyvesi E, Szabo G, Vecsernyes M, Bacskay I. Kiss T, et al. Among authors: fenyvesi f, fenyvesi e. Pharmazie. 2007 Jul;62(7):557-8. Pharmazie. 2007. PMID: 17718201

6

[Cytotoxic examinations of various cyclodextrin derivatives on Caco-2 cells].

Kiss T, Fenyvesi F, Kovácsné BI, Fehér P, Leposáné KR, Váradi J, Szente L, Fenyvesi E, Iványi R, Vecsernyés M. Kiss T, et al. Among authors: fenyvesi f, fenyvesi e. Acta Pharm Hung. 2007;77(2):150-4. Acta Pharm Hung. 2007. PMID: 17933275 Hungarian.

7

P-glycoprotein inhibition by membrane cholesterol modulation.

Fenyvesi F, Fenyvesi E, Szente L, Goda K, Bacsó Z, Bácskay I, Váradi J, Kiss T, Molnár E, Janáky T, Szabó G Jr, Vecsernyés M. Fenyvesi F, et al. Among authors: fenyvesi e. Eur J Pharm Sci. 2008 Aug 7;34(4-5):236-42. doi: 10.1016/j.ejps.2008.04.005. Epub 2008 Apr 29. Eur J Pharm Sci. 2008. PMID: 18539442

8

Evaluation of the cytotoxicity of beta-cyclodextrin derivatives: evidence for the role of cholesterol extraction.

Kiss T, Fenyvesi F, Bácskay I, Váradi J, Fenyvesi E, Iványi R, Szente L, Tósaki A, Vecsernyés M. Kiss T, et al. Among authors: fenyvesi f, fenyvesi e. Eur J Pharm Sci. 2010 Jul 11;40(4):376-80. doi: 10.1016/j.ejps.2010.04.014. Epub 2010 Apr 29. Eur J Pharm Sci. 2010. PMID: 20434542

9

Randomly methylated β-cyclodextrin derivatives enhance taxol permeability through human intestinal epithelial Caco-2 cell monolayer.

Fenyvesi F, Kiss T, Fenyvesi E, Szente L, Veszelka S, Deli MA, Váradi J, Fehér P, Ujhelyi Z, Tósaki A, Vecsernyés M, Bácskay I. Fenyvesi F, et al. Among authors: fenyvesi e. J Pharm Sci. 2011 Nov;100(11):4734-44. doi: 10.1002/jps.22666. Epub 2011 Jun 9. J Pharm Sci. 2011. PMID: 21660974

10

Cytotoxicity testing of carrier-based microcomposites for DPI application.

Ambrus R, Pomázi A, Réti-Nagy K, Fenyvesi F, Vecsernyés M, Szabó-Révész P. Ambrus R, et al. Among authors: fenyvesi f. Pharmazie. 2011 Jul;66(7):549-50. Pharmazie. 2011. PMID: 21812334

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

87 results

Search Page